1 / 21

Thyroid Autoimmune Diseases:

Thyroid Autoimmune Diseases: . Mechanism of development of Autoimmune endocrine disease : Two factors could be involved in development of human autoimmune disorders: 1-Expression of Class II HLA (human leukocyte antigen) on the surface of target endocrine cells.

martha
Télécharger la présentation

Thyroid Autoimmune Diseases:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Thyroid Autoimmune Diseases: Mechanism of development of Autoimmune endocrine disease: Two factors could be involved in development of human autoimmune disorders: 1-Expression of Class II HLA (human leukocyte antigen) on the surface of target endocrine cells. Infectious agent Inflammatory cells chemotaxis(INFγ) (or Self-antigen) Expression of HLA Presentation of own cellular proteins; reactive T and B cell response.

  2. N 2-The antigen Cross-reactivity: external organic material or infectious agents epitopesShow antigenic cross- reactivity with target tissues. formation of Auto-reactive Humoral immune response antibodies. Tissue destruction.

  3. Chronic lymphocytic Thyroiditis:(Hashimoto’s thyroiditis): Definition: -It is an autoimmune disease in which the thyroid gland is attacked by a variety of cell- and antibody-mediated immuneprocesses. -The first disease recognized as autoimmune disease. -Described by the Japanese specialist (Hakaru Hashimoto) in Germany in 1912. -Hypothyroidism, large and lobulated thyroid gland. -Enlargement of thyroid due to lymphocytic infiltration and fibrosis.

  4. n General considerations: -Family history of thyroid disease and HLA gene polymorphism (DR4, DR5). -CTLA-4 (Cytotoxic T-Lymphocyte gene A-4) Polymorphism; results in reduced negative regulation of T-lymphocytes. -Studies on Monozygotic twins show: Anti-Thyroid Antibodies (Gene homology of 80%). Other Risk factors: -Infectious agents : Human Herpes Virus-6 (A, and B). -Chromosomal disorders: Turner ,Klinefelter’s, and Down’s Syndrome. - Pollutants (Tobacco smoke).

  5. n -Most common in middle-agedand starts in adulthood. - 5-10 times more common in woman than in men. -Associated with other autoimmune diseases such as: Systemic lupus erythematosus, dermatitis, and scleroderma. Major Immunologic features of Hashimoto’s thyroiditis: 1-The lymphocytic infiltration of the thyroid gland. 2-The Antibodies against thyroid antigens are present. 3-The cellular sensitization to thyroid antigens.

  6. n Pathogenesis: -Expression of MHC Class II-self epitope complex on the thyroid cuboidal cell surface. -Thyroid cell-CD4+Lymphocyte interaction. -Cytokines production, and chemotaxis of CTL and Macrophage. -CTL-Thyroid cell interaction; Loss of T lymphocyte suppressor function due to CTL gene A mutation. -Killing of target cell by CTL; Apoptosis. -Engulfment of cellular peptide by macrophage; Ag presentation.

  7. n -Formation of Auto-reactive antibodies; Anti-thyroid peroxidase, and Anti-thyroglobulinAntibodies. -Sensitizationof Thyroid tissue ( thyrocyte). -ADCC for cuboidal cells lining the thyroid follicles by CD8+and N.K cells.

  8. n Histologically: -Diffuse parenchymal infiltration of lymphocyte; mainly B- lymphocytes which can be seen as secondary lymphoid follicles (Germinal center). -Hǖrthle cell ( Kari Hurthle) could be seen in tissue or cytology. -Hurthle cell: metaplasia from cuboidal cells lining the thyroid follicles characterized by eosinophilic-granular cytoplasm.

  9. N Germinal center: lymphocyte infiltrate. Pink reactive dying thyroid cell : Immunohistochemistry for P63. with cytoplasmic-acidophilic granules. :Positive in Germinal center (H.T).

  10. Clinical Features of Chronic thyroiditis: Primary stage: -Clinical hyperthyroidism due to inflammatory breakdown of thyroid follicles ( Silent, Painless inflammation). Late stage: -Hypothyroidism due to progressive destruction of thyroid tissue and cellular malfunction. -The most common outcome of Hashimoto’s disease is the hypothyroidism.

  11. Clinical presentation of Chronic thyroiditis: -A consistent physical sign seen in Hashimoto’s disease is an enlarged thyroid gland (Goiter). (Rubbery-nodular thyroid). - Lymph nodes surrounding the gland become enlarged. - Depression, Fatigue, Constipation, and dry skin. -Rarely, Symptoms of generalized vasculitiswith urticaria and nephritis could be seen due to presence of circulating immune complexes.

  12. Differential diagnosis of Chronic thyroiditis: -The hallmark of the diagnosis of this disease is the presence of circulating Autoantibodies: 1-Anti-thyroglobulin antibodies. (Antibodies titer) 2-Anti-thyroid peroxidase antibodies.(Antibodies titer). -These antibodies show a sensitivity of 90% and detected by: 1-Immunofluorescenceassay(Colloid aspiration). 2-ELISA. 3-Agglutinationassay. -In Seronegative patients , autoantibodies are localized in intrathyroidal lymphoid follicles.

  13. Graves’ Disease: Definition: -It is an autoimmune disease where the thyroid is activated by anti-TSHreceptorautoantibodies to produce excessive amount of thyroid hormones. -The most common cause of hyperthyroidism (60-90% of all cases). -It has a powerful hereditary component, affects up to 2% of the female population, and is between five and ten timesas common in females as in males.

  14. n General Considerations: -Hyperthyroidism and thyrotoxicosis with a diffuse goiter. - About 30-50% of people with Graves' disease will also suffer from Graves' ophthalmopathy caused by inflammation of the eye muscles by attacking autoantibodies. Exophthalmos: upper eyelid retraction, edema, erythema, and Graves’ Goiter: hyperthyroidism conjunctivitis.

  15. N -Specific cross-reactivity between some microbes (Viruses; Coxsackievirus, and bacteria; Yersinia enterocolitica) and TSH-Receptor of thyroid follicular cells. -Strong association with DR3, DQα , and DQβgenotype of MHC II haplotypes. -Family History: The disease is associated with different types of generalized autoimmune susceptibility; such as Hashimoto’s disease and antibodies to gastric intrinsic factors.

  16. N Clinical presentation: -Goiter, exophthalmos(30-50%), muscle weakness, weight loss, diarrhea and frequent defecation, hyperactivity ,tachycardia, hair loss, and Oligomenorrhea. Major Immunologic features of Graves’ disease: 1-Antibodies against thyroid antigen (TSH-R) are present; that stimulate thyroid cell function. 2-Class II HLA expression on the surface of thyroid cells. 3-Associated autoimmune ophthalmopathy.

  17. Graves’ disease Pathogenesis : -Autoantibodies present against TSH-receptor: 1- Thyroid-stimulating immunoglobulins (TSI): Activate TSH-receptor; elevated thyroid hormones. 2-Thyroid growth immunoglobulins( TGI) : Growth of thyroid follicles. 3-Thyroidbinding-inhibitingimmunoglobulins (TBII) : Inhibits TSH binding. -No Cellular immune response; Histology show no destruction of thyroid tissues. -Colloid suspension show lymphocytic infiltration: CD4, CD8, and B lymphocytes.

  18. Pathogenesis mechanism of Graves’ disease: N

  19. Diagnosis of Graves’ disease: -Clinically: Signs and symptoms of hyperthyroidism. -Radiology: Increased uptake of radioactive iodine. -Serology: A-Elevated Total and free T4, and T3. B-Identification of Anti-thyroid antibodies in patient’s sera: 1-Antibodies that activatecellular cAMP; Thyroid stimulating Immunoglobulin (TSI). 2-Thyroid growth stimulating immunoglobulins (TGI). 3-Antibodies that displace the binding of TSH from its receptor (TBII).

  20. N Anti-thyroid antibodies could be detected by: 1-ELISA Test: Microtiter plate wells should be coated by recombinant Human TSH-receptors. 2-Tissue culture (Fisher Rat thyroid cell line 5): -It can be used to measure the presence and activity of Anti-thyroid antibodies ( IgG) in patient's sera. -Serum specimens should be incubated with cell line culture; then : The cAMP activity and the incorporation of radioactivethymidine are measured.

  21. n N

More Related